• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓间充质干细胞衍生的外泌体 miR-744-5p 通过靶向 NFIX 缓解阻塞性睡眠呼吸暂停诱导的心肌损伤。

Bone Marrow Mesenchymal Stem Cell-Derived Exosomal MiR-744-5p Alleviates Obstructive Sleep Apnea-Induced Myocardial Injury by Targeting NFIX.

机构信息

Department of Otolaryngology, The Second Affiliated Hospital of Fujian Medical University.

出版信息

Int Heart J. 2024;65(6):1144-1152. doi: 10.1536/ihj.24-338.

DOI:10.1536/ihj.24-338
PMID:39617504
Abstract

Obstructive sleep apnea (OSA) is characterized by repetitive pharyngeal collapses during sleep, which leads to intermittent hypoxia, a risk factor of OSA-related cardiovascular morbidity.In this work, exosome isolation and identification with ultracentrifugation, transmission electron microscopy, nanoparticle tracking analysis, and Western blot assay were carried out. H9C2 cells were subjected to chronic intermittent hypoxia (CIH) treatment, which was followed by bone marrow mesenchymal stem cell (BMSC) -derived exosome treatment. Through reverse transcription-quantitative polymerase chain reaction (RT-qPCR), the expression of miR-744-5p was determined. Using corresponding commercial kits, the levels of oxidative stress indicators and inflammatory factors were measured. The potential target genes of miR-744-5p were predicted using four publicly target-predicting databases. To verify the interaction between miR-744-5p and NFIX, RNA pulldown and luciferase reporter assays were conducted.Significant upregulated expression of miR-744-5p in BMSC-derived exosomes was observed. The exosomes derived from miR-744-5p-overexpressing BMSCs (miR-744-5p mimics/Exo) promoted cell viability and reduced excessive inflammation and oxidative stress. Additionally, the intermolecular interaction between miR-744-5p and NFIX was determined. The exosomes derived from BMSCs cotransfecting with NFIX overexpression plasmid and miR-744-5p mimics reversed the miR-744-5p mimics/Exo-induced inhibitory effects on CIH-caused cardiomyocyte injury.BMSC-derived exosomal miR-744-5p suppressed OSA-induced cardiomyocyte damage by targeting NFIX.

摘要

阻塞性睡眠呼吸暂停(OSA)的特征是睡眠期间咽腔反复塌陷,导致间歇性缺氧,这是 OSA 相关心血管发病率的一个危险因素。在这项工作中,通过超速离心、透射电子显微镜、纳米颗粒跟踪分析和 Western blot 检测进行了外泌体分离和鉴定。将 H9C2 细胞进行慢性间歇性缺氧(CIH)处理,随后进行骨髓间充质干细胞(BMSC)衍生的外泌体处理。通过逆转录定量聚合酶链反应(RT-qPCR)测定 miR-744-5p 的表达。使用相应的商业试剂盒测定氧化应激指标和炎症因子的水平。使用四个公共靶标预测数据库预测 miR-744-5p 的潜在靶基因。为了验证 miR-744-5p 与 NFIX 之间的相互作用,进行了 RNA 下拉和荧光素酶报告基因检测。观察到 BMSC 衍生的外泌体中 miR-744-5p 的表达显著上调。来自 miR-744-5p 过表达 BMSC 的外泌体(miR-744-5p 模拟物/Exo)促进了细胞活力,减少了过度的炎症和氧化应激。此外,还确定了 miR-744-5p 和 NFIX 之间的分子间相互作用。共转染 NFIX 过表达质粒和 miR-744-5p 模拟物的 BMSC 衍生的外泌体逆转了 miR-744-5p 模拟物/Exo 诱导的对 CIH 引起的心肌细胞损伤的抑制作用。BMSC 衍生的外泌体 miR-744-5p 通过靶向 NFIX 抑制 OSA 诱导的心肌细胞损伤。

相似文献

1
Bone Marrow Mesenchymal Stem Cell-Derived Exosomal MiR-744-5p Alleviates Obstructive Sleep Apnea-Induced Myocardial Injury by Targeting NFIX.骨髓间充质干细胞衍生的外泌体 miR-744-5p 通过靶向 NFIX 缓解阻塞性睡眠呼吸暂停诱导的心肌损伤。
Int Heart J. 2024;65(6):1144-1152. doi: 10.1536/ihj.24-338.
2
Mesenchymal Stem Cell-Originated Exosomal Lnc A2M-AS1 Alleviates Hypoxia/Reperfusion-Induced Apoptosis and Oxidative Stress in Cardiomyocytes.间质干细胞源性外泌体 Lnc A2M-AS1 减轻心肌细胞缺氧/复氧诱导的细胞凋亡和氧化应激。
Cardiovasc Drugs Ther. 2023 Oct;37(5):891-904. doi: 10.1007/s10557-022-07339-7. Epub 2022 May 11.
3
Lipopolysaccharide-stimulated bone marrow mesenchymal stem cells-derived exosomes inhibit H2O2-induced cardiomyocyte inflammation and oxidative stress via regulating miR-181a-5p/ATF2 axis.脂多糖刺激骨髓间充质干细胞衍生的外泌体通过调节 miR-181a-5p/ATF2 轴抑制 H2O2 诱导的心肌细胞炎症和氧化应激。
Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):10069-10077. doi: 10.26355/eurrev_202010_23224.
4
Exosomes of bone-marrow stromal cells inhibit cardiomyocyte apoptosis under ischemic and hypoxic conditions via miR-486-5p targeting the PTEN/PI3K/AKT signaling pathway.骨髓基质细胞来源的外泌体通过 miR-486-5p 靶向 PTEN/PI3K/AKT 信号通路抑制缺血缺氧条件下的心肌细胞凋亡。
Thromb Res. 2019 May;177:23-32. doi: 10.1016/j.thromres.2019.02.002. Epub 2019 Feb 2.
5
Hypoxic BMSC-derived exosomal miR-210-3p promotes progression of triple-negative breast cancer cells via NFIX-Wnt/β-catenin signaling axis.缺氧的骨髓间充质干细胞衍生的外泌体miR-210-3p通过NFIX-Wnt/β-连环蛋白信号轴促进三阴性乳腺癌细胞的进展。
J Transl Med. 2025 Jan 9;23(1):39. doi: 10.1186/s12967-024-05947-5.
6
Bone marrow mesenchymal stem cell-derived exosomes carrying long noncoding RNA ZFAS1 alleviate oxidative stress and inflammation in ischemic stroke by inhibiting microRNA-15a-5p.携带长链非编码RNA ZFAS1的骨髓间充质干细胞来源外泌体通过抑制微小RNA-15a-5p减轻缺血性中风中的氧化应激和炎症。
Metab Brain Dis. 2022 Oct;37(7):2545-2557. doi: 10.1007/s11011-022-00997-4. Epub 2022 Jul 30.
7
MiR-183-5p overexpression in bone mesenchymal stem cell-derived exosomes protects against myocardial ischemia/reperfusion injury by targeting FOXO1.骨间充质干细胞来源的外泌体中 miR-183-5p 的过表达通过靶向 FOXO1 保护心肌缺血/再灌注损伤。
Immunobiology. 2022 May;227(3):152204. doi: 10.1016/j.imbio.2022.152204. Epub 2022 Mar 7.
8
Exosomal miR-9-5p derived from BMSCs alleviates apoptosis, inflammation and endoplasmic reticulum stress in spinal cord injury by regulating the HDAC5/FGF2 axis.源自骨髓间充质干细胞的外泌体miR-9-5p通过调节HDAC5/FGF2轴减轻脊髓损伤中的细胞凋亡、炎症和内质网应激。
Mol Immunol. 2022 May;145:97-108. doi: 10.1016/j.molimm.2022.03.007. Epub 2022 Mar 19.
9
Bone marrow mesenchymal stem cell-derived exosomes shuttling miR-150-5p alleviates mechanical allodynia in rats by targeting NOTCH2 in microglia.骨髓间充质干细胞来源的外泌体通过靶向小胶质细胞中的 NOTCH2 缓解大鼠机械性痛觉过敏。
Mol Med. 2022 Nov 8;28(1):133. doi: 10.1186/s10020-022-00561-x.
10
Exosomes Derived from Mesenchymal Stem Cells Increase the Viability of Damaged Endometrial Cells via the miR-99b-5p/PCSK9 Axis.间充质干细胞来源的外泌体通过 miR-99b-5p/PCSK9 轴增加受损子宫内膜细胞的活力。
Stem Cells Dev. 2024 Jun;33(11-12):290-305. doi: 10.1089/scd.2023.0259. Epub 2024 May 8.

引用本文的文献

1
Stem-Cell Derived Exosomal microRNAs as Biomarkers and Therapeutics for Pediatric Cardiovascular Disease.干细胞衍生的外泌体微小RNA作为儿科心血管疾病的生物标志物和治疗方法
Curr Treat Options Cardiovasc Med. 2025;27(1):32. doi: 10.1007/s11936-025-01088-0. Epub 2025 Apr 9.